Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Robotic Brace Incorporating Electromyography (EMG) for Moderate Affected Arm Impairment After Stroke

NCT01322997 · University of Cincinnati · Updated 25 March 2011

What is being tested
Myomo e100 Robot and repetitive task specific training; Repetitive task specific training (RTP) targeting the affected arm; Myomo e100 neurorobotic brace
For
Stroke
Kind of study
Tests a treatment or device on volunteers. Phase 1 and Phase 2.
Who can join
Ages 35 years to 85 years. About 30 people. The full rules are on the registry page.
Where
United States
When
Starts or started Sept 2010, ends May 2012. Registered 25 March 2011.
Results
None posted yet.

In the researchers' words

Stroke is the leading cause of disability in the United States. One of the reasons that it is so disabling is because of upper extremity hemiparesis (weakness in one arm), which is commonly seen after stroke. The objective of this research is to see if a robotic system worn on the weakened arm like a brace is more useful in improving the strength and coordination of the affected arm, and those of other stroke survivors, than therapy only. Muscle weakness and lack of coordination after a stroke have great effects on how severely disabled the arm is and on quality of life after a stroke. In this study, patients may be administered a new robotic brace as part of treatment for their affected arms. If they use this brace, your electromyography (EMG) signals will be used to control the powered arm brace. EMG signals are the small electrical signals that result from the actions of the muscles. The system will "listen" to patients' muscles, using small sensors that sit on top of the skin. The device will give the arm a "power-assist" when patients bend or straighten their elbows. The investigators want to test how easy and effective this system is to use. The investigators hypothesize that people using the robot will be more successful in their rehabilitative efforts - and that their movement will improve more - than people receiving traditional therapy.
ClinicalTrials.gov, NCT01322997

Sites

  • Univcersity of CincinnatiCincinnati, Ohio, United States